Top 50 Pharma Tracker: eHCPs celebrate vaccine data from Novavax and Moderna approval

01.10.2023 | Tracker

Top 50 Pharma Tracker: eHCPs celebrate vaccine data from Novavax and Moderna approval

Discover what healthcare professionals (eHCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are eHCPs responding to drug launch news? How are eHCPs talking about or engaging with the Top 50 pharma companies on social media? Each week, CREATION.co’s tracking updates bring you the latest insights from the conversation of eHCPs across the globe discussing these topics and more.

The Top 50 Pharmaceutical Companies mentioned by eHCPs on X

September RankAugust RankCompany
Name
Total
Mentions
Account
Mentions
Account
Retweets
11Pfizer4,32337411
22Moderna2,8252329
34Johnson & Johnson1,17849719
47Novavax76212417
56AstraZeneca5783799
614BioNTech386360
73GSK33411732
89Bayer2216010
911Abbott21720410
105Novo Nordisk213789
1117Novartis2001263
1212Roche1958311
1310Sanofi1819223
1413Merck & Co148995
1520AbbVie138767
1618Gilead Sciences136400
1732Takeda110950
1816Lilly92516
1923Amgen90765
2015BMS88752
218Otsuka80130
2224Boehringer Ingelheim76656
2329Fresenius57282
2424Regeneron42181
2426Organon3810
2637Merck KGaA36368
2733Viatris3200
2819Daiichi Sankyo2741
2939UCB21154
2922Biogen2080
3128Astellas19110
3233Ipsen18171
3321Teva17136
3327Servier1765
3543Menarini1480
3629Eisai12102
3731Bausch1150
3843Horizon1080
3939CSL882
3935Vertex760
4138Incyte620
4141Chugai533
4343Grifols300
4336Sun110
4341CSPC000
4343Jazz Pharmaceuticals000
4343Sino000
5050Perrigo000
5050Shanghai000
5050Jiangsu Hengrui000

The latest insights from eHCPs mentioning the Top 50 Pharmaceutical Companies

The five pharmaceutical companies that were mentioned the most by eHCPs on X (formerly Twitter) in September 2023 were Pfizer, Moderna, Johnson & Johnson, Novavax, and AstraZeneca.

CREATION.co identified 10,648 eHCP mentions of pharmaceutical companies in September 2023, increasing by 4.9% over the previous month.

On 06 September, oncologist Shruti Patel authored a Tweetorial for her peers. She shared data relating to the efficacy of nivolumab and chemotherapy for patients. Many eHCPs responded to the Tweetorial by sharing and liking posts, in addition to responding to polls. The Tweetorial was part of a weekly board called #TumorBoardTuesday, where eHCPs participate in polls, cancer treatment discussions and patient diagnosis journeys. This particular #TumorBoardTuesday was supported by many pharmaceutical companies through educational grants, including Janssen, AstraZeneca, Merck, Seagen, Exelixis and Astellas.

On 12 September, Moderna’s COVID-19 vaccine was approved for use in Canada. Epidemiologist Raywat Deonandan took the opportunity to share the news and celebrate the reduced risk of worse outcomes but warned readers to be careful of potential noise and misinformation. His post was shared by 12 eHCPs.

Despite awaiting approval, Novavax’s COVID-19 vaccine has received praise for its positive results and high efficacy from eHCPs. Paediatrician Dr. Vipin Vashishtha said that the results are “living up to its original hype”. The post was shared by three other eHCPs.

The top shared links by eHCPs when mentioning a Top 50 pharma company discussed:

  1. A document sharing the details of HCPs in a Canadian patient support program for Schizophrenia and Bipolar Type I Disorder.
  2. An article from the FDA warning the public about the use of the antipsychotic drug aripiprazole affecting a patient’s impulsive decision-making.
  3. A Wikipedia article linking to the COVID-19 pandemic.

CREATION.co continues to analyse online eHCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.

To stay up to date, you can sign up to CREATION.co’s monthly eJournal or review all previous editions of the Top 50 Pharma Tracker.

Methodology notes:

    • In September 2023, CREATION Pinpoint® identified 10,648 healthcare professional authored posts on X (Twitter) from 3,985 individual eHCPs mentioning a Top 50 Pharmaceutical company (according to revenue). 
    • Data for this research was analysed from the online X conversations of eHCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 – 30 September 2023.
    • Unless otherwise specified, mentions of a company are not limited to its X account(s).
    • In some cases, an X post may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
    • Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Janssen. In September 2023, 486 of these posts mentioned Janssen.

 

Share this article

Meet the Author

Aman Jandu

With a background working in IT systems administration, and leveraging a 1st Class degree in Digital Technologies, Aman uses his technical skills to apply a systematic approach to gather data and analyse insights.

Aman loves to Speedcube. While he can currently solve a Rubik’s Cube in around 20 seconds, he is learning how to complete it blindfolded.

Suggested next


05.09.2022 | Article

Respiratory tracker: Climate crisis = Health crisis, HCPs share their opinions at ERS 2022

The most shared post was on the dangers of misinformation and why context is important

By Mark Sullivan

16.12.2020 | Article

#WhatHCPsthink about COVID-19’s impact on cancer diagnosis and treatment

The effect of COVID-19 on cancer diagnosis and treatment

By Lara Meyer

View all articles >